Morphological and immunophenotypic variations in malignant melanoma

Histopathology

Volumn 36, Issue 5, 2000, Pages 387-402

  Banerjee, S S ^a   Harris, M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Immunophenotypic aberration; Malignant melanoma; Morphological variation

Indexed keywords

ACTIN; CYTOKERATIN; DESMIN; MONOCLONAL ANTIBODY; PROTEIN S 100;

CELL DIFFERENTIATION; CELL SHAPE; CELL STRUCTURE; CYTOARCHITECTURE; GIANT CELL; HISTOPATHOLOGY; IMMUNOPHENOTYPING; MELANOMA; OSTEOCLAST; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNET RING CARCINOMA; SPINDLE CELL; STROMA; VASCULARIZATION;

DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOPHENOTYPING; MELANOMA;

EID: 0034064105     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2000.00894.x     Document Type: Review

References (118)

1. 1. Levene A. On the histological diagnosis and prognosis of malignant melanoma. J. Clin. Pathol. 1980; 33; 101-124.
2. 2. Reed WB, Becker SW Sr, Becker SW Jr, Nickel WR. Giant pigmented nevi, melanoma and leptomeningeal melanocytosis. Arch. Dermatol. 1965; 91; 100-119.
3. 3. Hendrickson MR, Ross JC. Neoplasms arising in congenital giant nevi: Morphologic study of seven cases and a review of the literature. Am. J. Surg. Pathol. 1981; 5; 109-135.
4. 4. Nakhleh RE, Wick MR, Rocamora A, Swanson PE, Dehner LP. Morphologic diversity in malignant melanomas. Am. J. Clin. Pathol. 1990; 93; 731-740.
5. 5. Fitzgibbons PL, Martin SE, Simmons TJ. Malignant melanoma metastatic to the ovary. Am. J. Surg. Pathol. 1987; 11; 959-964.
6. 6. Young RH, Scully RE. Malignant melanoma metastatic to the ovary: a clinico-pathologic analysis of 20 cases. Am. J. Surg. Pathol. 1991; 15; 849-860.
7. 7. Franquemont DW, Mills SE. Sinonasal malignant melanoma. A clinicopathologic and immunohistochemical study of 14 cases. Am. J. Clin. Pathol. 1991; 96; 689-697.
8. 8. Attanoos R, Griffiths DFR. Metastatic small cell melanoma to the stomach mimicking primary gastric lymphoma. Histopathology 1992; 21; 173-175.
9. 9. Reed RJ. Giant congenital nevi: a conceptualization of patterns. J. Invest. Dermatol. 1993; 10 (Suppl.); 300-312.
10. 10. House NS, Fedok F, Maloney ME, Helm KF. Malignant melanoma with clinical and histologic features of Merkel cell carcinoma. J. Am. Acad. Dermatol. 1994; 31; 839-842.
11. 11. Barnhill RL, Flotte TJ, Fleischli M, Perez-Atayde A. Cutaneous melanoma and atypical Spitz tumors in childhood. Cancer 1995; 76; 1833-1845.
12. 12. Kossard S, Wilkinson B. Nucleolar organizer regions and image analysis nuclear morphometry of small cell (nevoid) melanoma. J. Cutan. Pathol. 1995; 22; 132-136.
13. 13. Barnhill RL. Childhood melanoma. Sem. Diag. Pathol. 1998; 15; 189-194.
14. 14. Regauer S, Anderhuber W, Richtig E, Schachenreiter J, Ott A, Beham A. Primary mucosal melanomas of the nasal cavity and paranasal sinuses. A clinicopathological analysis of 14 cases. APMIS 1998; 106; 403-410.
15. 15. Lodding P, Kindblom L, Angervall L. Metastases of malignant melanoma simulating soft tissue sarcoma. Virch. Archiv. A. Pathol. Anat. 1990; 417; 377-388.
16. 16. Dimaio SM, MacKay B, Smith JL Jr, Dickersin GR. Neurosarcomatous transformation in malignant melanoma: an ultrastructural study. Cancer 1982; 50; 2345-2354.
17. 17. Macak J, Krc I, Elleder M, Lukas Z. Clear cell melanoma of the skin with regressive changes. Histopathology 1991; 18; 276-277.
18. 18. Mourad WA, MacKay B, Ordonez NG, Ro JY, Swanson DA. Clear cell melanoma of the bladder. Ultrastruct. Pathol. 1993; 17; 463-468.
19. 19. Ehara H, Takahashi Y, Saitoh A, Kawada Y, Shimokawa K, Kanemura T. Clear cell melanoma of the renal pelvis presenting as a primary tumour. J. Urol. 1997; 157; 634.
20. 20. Chung EB, Enzinger FM. Malignant melanoma of soft parts: a reassessment of clear cell sarcoma. Am. J. Surg. Pathol. 1983; 7; 405-413.
21. 21. Sheibani K, Battifora H. Signet ring cell melanoma: a rare morphologic variant of malignant melanoma. Am. J. Surg. Pathol. 1988; 12; 28-34.
22. 22. Bonetti F, Colombari R, Zamboni G, Chilosi M, Legnami F. Signet ring melanoma, S100 negative (letter). Am. J. Surg. Pathol. 1989; 13; 522-523.
23. 23. Al-Talib RK, Theaker JM. Signet-ring cell melanoma: light microscopic, immunohistochemical and ultrastructural features. Histopathology 1991; 18; 572-575.
24. 24. Eckert F, Baricevic B, Landthaler M, Schmid U. Metastatic signetring cell melanoma in a patient with an unknown primary tumor. J. Am. Acad. Dermatol. 1992; 26; 870-875.
25. 25. Livolsi VA, Brooks JJ, Soslow R, Johnson BL, Elder DE. Signet cell melanocytic lesions. Mod. Pathol. 1992; 5; 515-520.
26. 26. Tsang WYW, Chan JKC, Chow LTC. Signet-ring cell melanoma mimicking adenocarcinoma: a case report. Acta Cytol. 1993; 37; 559-562.
27. 27. Bittesini L, Dei Tos AP, Fletcher CDM. Metastatic malignant melanoma showing a rhabdoid phenotype: further evidence of a non-specific histological pattern. Histopathology 1992; 20; 167-170.
28. 28. Chang ES, Wick MR, Swanson PE, Dehner LP. Metastatic malignant melanoma with 'rhabdoid' features. Am. J. Clin. Pathol. 1994; 102; 426-431.
29. 29. Borek BT, McKee PH, Freeman JA, Maguire B, Brander WL, Calonje E. Primary malignant melanoma with rhabdoid features: a histologic and immunocytochemical study of three cases. Am. J. Dermatopathol. 1998; 20; 123-127.
30. 30. Gardner WA, Vazquez M. Balloon cell melanoma. Arch. Pathol. Lab. Med. 1970; 89; 470-472.
31. 31. Ranchod M. Metastatic melanoma with balloon cell changes. Cancer 1972; 30; 1006-1013.
32. 32. Sondergaard K, Henschel A, Hou-Jensen K. Metastatic melanoma with balloon cell changes: an electron microscopic study. Ultrastruct. Pathol. 1980; 1; 357-360.
33. 33. Peters MS, Su DWP. Balloon cell malignant melanoma. J. Am. Acad. Dermatol. 1985; 13; 351-354.
34. 34. Kao GF, Helwig EB, Graham JH. Balloon cell malignant melanoma of the skin: a clinicopathologic study of 34 cases with histochemical, immunohistochemical and ultrastructural observations. Cancer 1992; 69; 2942-2952.
35. 35. Mowat A, Reid R, MacKie R. Balloon cell metastatic melanoma: an important differential diagnosis of clear cell tumours. Histopathology 1994; 24; 469-472.
36. 36. Al-Nafussi AI, Hughes DE, Williams AR. Hyaline globules in ovarian tumours. Histopathology 1993; 23; 563-566.
37. 37. Severi B, Pasquinelli G, Martinelli GN, Zanetti GF, Santini D. Hyaline globules in ovarian tumours. Histopathology 1994; 25; 299.
38. 38. Monteagudo C, Jorda E, Carda C, Illueca C, Peydro A, Llombart-Bosch A. Erythrophagocytic tumour cells in melanoma and squamous cell carcinoma of the skin. Histopathology 1997; 31; 367-373.
39. 39. Mooi WJ, Krausz T. Cutaneous melanoma. In: Biopsy Pathology of Melanocytic Disorders. London: Chapman & Hall, 1992: 283-287.
40. 40. Shanks JH, Banerjee SS. VS38 immunostaining in melanocytic lesions. J. Clin. Pathol. 1996; 49; 205-207.
41. 41. Bhuta S, Mirra JM, Cochran AJ. Myxoid malignant melanoma: a previously undescribed histologic pattern noted in metastatic lesions and a report of four cases. Am. J. Surg. Pathol. 1986; 10; 203-211.
42. 42. Nottingham JF, Slater DN. Malignant melanoma: a new mimic of colloid adenocarcinoma. Histopathology 1988; 13; 576-578.
43. 43. Garcia-Caballero T, Fraga M, Antunez JR, Perez-Becerra E, Beiras A, Forteza J. Myxoid metastatic melanoma. Histopathology 1991; 18; 371-373.
44. 44. Sarode VR, Joshi K, Ravichandran P, Das R. Myxoid variant of primary cutaneous malignant melanoma. Histopathology 1992; 20; 186-187.
45. 45. Chetty R, Slavin JL, Pitson GA, Dowling JP. Melanoma botryoides: a distinctive myxoid pattern of sino-nasal malignant melanoma. Histopathology 1994; 24; 377-379.
46. 46. McCluggage WG, Shah V, Toner PG. Primary cutaneous myxoid malignant melanoma. Histopathology 1996; 28; 179-182.
47. 47. Collina G, Losi L, Taccagni GL, Mairona A. Myxoid metastases of melanoma: Report of three cases and review of the literature. Am. J. Dermatopathol. 1997; 19; 52-57.
48. 48. Hitchcock MG, White WL. Malicious masquerade: Myxoid melanoma. Sem. Diagn. Pathol. 1998; 15; 195-202.
49. 49. Conley J, Lattes R, Orr W. Desmoplastic melanoma (a rare variant of spindle cell melanoma). Cancer 1971; 28; 914-936.
50. 50. Frolow GR, Shapiro L, Brownstein MH. Desmoplastic malignant melanoma. Arch. Dermatol. 1975; 111; 753-754.
51. 51. Labreque PG, Hu C, Winkelman RK. On the nature of desmoplastic melanoma. Cancer 1976; 38; 1205-1213.
52. 52. Reed RJ, Leonard DD. Neurotropic melanoma (a variant of desmoplastic melanoma). Am. J. Surg. Pathol. 1979; 3; 301-311.
53. 53. From L, Hanna W, Kahn HJ, Gross J, Marks A, Baumal R. Origin of desmoplasia in desmoplastic malignant melanoma. Hum. Pathol. 1983; 4; 1072-1080.
54. 54. Moreno A, Lamarca J, Martinez R, Guix M. Osteoid and bone formation in desmoplastic malignant melanoma. J. Cut. Pathol. 1986; 13; 128-134.
55. 55. Reiman H, Goellner JR, Woods JE, Mixter RC. Desmoplastic melanoma of the head and neck. Cancer 1987; 60; 2269-2274.
56. 56. Kossard S, Doherty E, Murray E. Neurotropic melanoma: a variant of desmoplastic melanoma. Arch. Dermatol. 1987; 123; 907-912.
57. 57. Egbert B, Kempson R, Sagebiel R. Desmoplastic malignant melanoma: a clinicohistopathologic study of 25 cases. Cancer 1988; 62; 2033-2041.
58. 58. Jain S, Allen PW. Desmoplastic malignant melanoma and its variants: a study of 45 cases. Am. J. Surg. Pathol. 1989; 13; 358-373.
59. 59. Bruijn JA, Mihm MC Jr, Barnhill RL. Desmoplastic melanoma. Histopathology 1992; 20; 197-205.
60. 60. Anstey A, McKee P, Wilson-Jones E. Desmoplastic malignant melanoma: a clinicopathologic study of 25 cases. Br. J. Dermatol. 1993; 129; 359-371.
61. 61. Anstey A, Cerio R, Ramnarain N. Desmoplastic malignant melanoma, an immunocytochemical study of 25 cases. Am. J. Dermatopathol. 1994; 16; 14-22.
62. 62. Carlson JA, Dickersin GR, Sober AJ, Barnhill RL. Desmoplastic neurotropic melanoma. Cancer 1995; 75; 478-494.
63. 63. Longacre TA, Egbert BM, Rouse RV. Desmoplastic and spindle cell malignant melanoma. An immunohistochemical study. Am. J. Surg. Pathol. 1996; 20; 1489-1500.
64. 64. Wharton JM, Carlson JA, Mihm MC (Jr). Desmoplastic malignant melanoma: Diagnosis of early clinical lesions. Hum. Pathol. 1999; 33; 537-542.
65. 65. Gaudin PB, Rosai J. Florid vascular proliferation associated with neural and neuroendocrine neoplasms. Am. J. Surg. Pathol. 1995; 19; 642-652.
66. 66. Kepes JJ. Vascular proliferation (letter). Am. J. Surg. Pathol. 1996; 20; 384-386.
67. 67. Suster S, Moran CA. Unusual manifestations of metastatic tumors to the lungs. Sem. Diagn. Pathol. 1995; 12; 193-206.
68. 68. Adler MJ, Beckstead J, White CR. Angiomatoid melanoma: a case of metastatic melanoma mimicking a vascular malignancy. Am. J. Dermatopathol. 1997; 19; 606-609.
69. 69. Banerjee SS, Eyden BP, Wells S, McWilliam LJ, Harris M. Pseudoangiosarcomatous carcinoma: a clinicopathological study of seven cases. Histopathology 1992; 21; 13-23.
70. 70. Nappi O, Wick MR, Pettinato G, Ghiselli RW, Swanson PE. Pseudovascular adenoid squamous cell carcinoma of the skin: a neoplasm that may be mistaken for angiosarcoma. Am. J. Surg. Pathol. 1992; 16; 429-438.
71. 71. Coyne JD, Banerjee SS, Menasce LP, Mene A. Granulomatous lymphadenitis associated with metastatic malignant melanoma. Histopathology 1996; 28; 470-472.
72. 72. de Dulants F, Armijo-Moreno M, Camacho-Martinez F. Tuberculoid granulomata in regional lymph nodes of malignant cutaneous melanoma. Dermatologica 1974; 148; 228-232.
73. 73. Richmond I, Eyden BP, Banerjee SS. Intranodal Langerhans' cell histiocytosis associated with malignant melanoma. Histopathology 1995; 26; 380-382.
74. 74. Roufosse C, Lespagnard L, Sales F, Bron D, Dargent J. Langerhans' cell histiocytosis associated with simultaneous lymphocytic predominance Hodgkin's disease and malignant melanoma (letter). Hum. Pathol. 1998; 29; 200-201.
75. 75. Denton KJ, Stretch J, Athanasou N. Osteoclast-like giant cells in malignant melanoma. Histopathology 1992; 20; 179-181.
76. 76. Daroca PJ, Reed RJ, Martin PC. Metastatic amelanotic melanoma simulating giant cell tumor of bone. Hum. Pathol. 1990; 21; 978-980.
77. 77. Banerjee SS, Bishop PW, Nicholson CM, Eyden BP. Malignant melanoma showing smooth muscle differentiation. J. Clin. Pathol. 1996; 49; 950-951.
78. 78. Slaughter JC, Hardman JM, Kempe LG, Earle KM. Neurocutaneous melanosis and leptomeningeal melanomatosis in children. Arch. Pathol. 1969; 88; 298-304.
79. 79. Wahlstrom T, Saxen L. Malignant skin tumors of neural crest origin. Cancer 1976; 38; 2022-2026.
80. 80. Grunwald MH, Rothem A, Feuerman EJ. Metastatic malignant melanoma with cartilaginous metaplasia. Dermatologica 1985; 170; 249-252.
81. 81. Brisigotti M, Moreno A, Llistosella E, Prat J. Malignant melanoma with osteocartilaginous differentiation. Surg. Pathol. 1989; 2; 73-78.
82. 82. Pellegrini AE, Scalamogna PA. Malignant melanoma with osteoid formation. Am. J. Dermatopathol. 1990; 12; 607-611.
83. 83. Nakagawa H, Imakado S, Nogita T, Ishibahi Y. Osteosarcomatous changes in malignant melanoma: immunohistochemical and ultrastructural studies of a case. Am. J. Dermatopathol. 1990; 12; 162-168.
84. 84. Lucas DR, Tazelaar HD, Unni KK et al. Osteogenic melanoma: a rare variant of malignant melanoma. Am. J. Surg. Pathol. 1993; 17; 400-409.
85. 85. Hoorweg JJ, Loftus BM, Hilgers FJM. Osteoid and bone formation in a nasal mucosal melanoma and its metastasis. Histopathology 1997; 31; 465-468.
86. 86. Banerjee SS, Coyne JD, Menasce LP, Lobo CJ, Hirsch PJ. Diagnostic lessons of mucosal melanoma with osteocartilaginous differentiation. Histopathology 1998; 33; 255-260.
87. 87. Banerjee SS, Menasce LP, Eyden BP, Brain AN. Malignant melanoma showing ganglioneuroblastic differentiation: Report of a unique case. Am. J. Surg. Pathol. 1999; 23; 582-588.
88. 88. Cochran AJ, Wen D-R, Herschman HR, Gaynor RB. Detection of S100 protein as an aid to the identification of melanocytic tumors. Int. J. Cancer 1982; 30; 295-297.
89. 89. Wick MR, Swanson PE, De Manivel JC. Immunohistochemical findings in tumors of the skin. In: De Lellis RA, eds. Advances in Immunohistochemistry. New York: Raven, 1988: 395-429.
90. 90. Ordonez NG, Xiaolong JI, Hickey RC. Comparison of HMB-45 monoclonal antibody and S100 protein in the immunohistochemical diagnosis of melanoma. Am. J. Clin. Pathol. 1988; 90; 385-390.
91. 91. MacKie RM, Campbell I, Turbitt ML. Use of NKIC3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. J. Clin. Pathol. 1984; 37; 367-372.
92. 92. Vennegoor C, Calafat J, Hageman Ph et al. Biochemical characterization and cellular localization of a formalin-resistant melanoma-associated antigen reacting with monoclonal antibody NKI/C-3. Int. J. Cancer 1985; 35; 287-295.
93. 93. Thomson W, MacKie RM. Comparison of five antimelanoma antibodies for identification of melanocytic cells on tissue sections in rountine dermatopathology. J. Am. Acad. Dermatol. 1989; 21; 1280-1284.
94. 94. Gown AM, Vogel AM, Hoak D, Gough F, McNutt MA. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am. J. Pathol. 1986; 123; 195-203.
95. 95. Wick MR, Swanson PE, Rocamora A. Rocognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors. J. Cutan. Pathol. 1988; 15; 201-207.
96. 96. Bacchi CE, Bonetti F, Pea M, Martignoni G, Gown AM. HMB-45: a review. Appl. Immunohistochem. 1996; 4; 73-85.
97. 97. Chen YT, Stockert E, Jungbluth A et al. Serologic analysis of Melan-A (MART-1), a melanocyte specific protein homogeneously expressed in human melanomas. Proc. Natl. Acad. Sci. 1996; 93; 5915-5919.
98. 98. Fetsch PA, Cormier J, Hijazi YM. Immunocytochemical detection of MART-1 in fresh and paraffin embedded malignant melanomas. J. Immunother. 1997; 20; 60-64.
99. 99. Jungbluth AA, Busam KJ, Gerald WL et al. A103: an anti-melan A monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am. J. Surg. Pathol. 1998; 22; 595-602.
100. 100. Busam KJ, Chen Y-T, Old LJ et al. Expression of Melan-A (MART-1) in benign melanocytic naevi and primary cutaneous malignant melanoma. Am. J. Surg. Pathol. 1998; 22; 976-982.
101. 101. Blessing K, Sanders DSA, Grant JJH. Comparison of immunohistochemical staining of the novel antibody Melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology 1998; 32; 139-146.
102. 102. Busam KJ, Jungbluth AA. Melan-A, a new melanocytic differentiation marker. Adv. Anat. Pathol. 1999; 6; 12-18.
103. 103. Takimoto H, Suzuki S, Masui S et al. MAT-1, a monoclonal antibody that specifically recognizes human tyrosinase. J. Invest. Dermatol. 1995; 105; 764-768.
104. 104. Bishop PW, Menasce LP, Yates AJ, Win NA, Banerjee SS. An immunophenotypic survey of malignant melanomas. Histopathology 1993; 23; 159-166.
105. 105. Calonje E, Wilson-Jones E, Smith NP, Fletcher CDM. Cellular 'neurothekeoma': an epithelioid variant of pilar leiomyoma? Morphological and immunohistochemical analysis of a series. Histopathology 1992; 20; 397-404.
106. 106. Shanks JH, Harris M, Banerjee SS, Eyden BP. Gastrointestinal autonomic nerve tumours: a report of nine cases. Histopathology 1996; 29; 111-121.
107. 107. Buley ID, Gatter KC, Kelly PMA, Heryet A, Millard PR. Granular cell tumours revisited. An immunohistological and ultrastructural study. Histopathology 1988; 12; 263-274.
108. 108. Busam KJ, Iversen K, Coplan KA et al. Immunoreactivity for A103, an antibody to Melan-A (MART-1), in adrenocortical and other steroid tumors. Am. J. Surg. Pathol. 1998; 22; 57-63.
109. 109. Fetsch PA, Fetsch JF, Marincola FM, Travis W, Batts KP, Abati A. Comparison of melanoma antigen recognized by T cells (MART-1) to HMB-45: additional evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis, and clear cell sugar tumor. Mod. Pathol. 1998; 11; 699-703.
110. 110. Miettinen M, Franssila K. Immunohistochemical spectrum of malignant melanoma: the common presence of keratins. Lab. Invest. 1989; 61; 623-628.
111. 111. Zarbo RJ, Gown AM, Nagle RB, Visscher DW, Crissman JD. Anomalous cytokeratin expression in malignant melanoma: one-and two-dimensional western blot analysis and immunohistochemical survey of 100 melanomas. Mod. Pathol. 1990; 3; 494-501.
112. 112. Ben-Izhak O, Stark P, Levy R, Bergman R, Lichtig C. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases. Am. J. Dermatopathol. 1994; 16; 241-246.
113. 113. Ben-Izhak O, Levy R, Weill S et al. Anorectal malignant melanoma. A clinicopathologic study, including immunohistochemistry and DNA flow cytometry. Cancer 1997; 79; 18-25.
114. 114. Selby WL, Nance KV, Park HK. CEA immunoreactivity in metastatic malignant melanoma. Mod. Pathol. 1992; 5; 415-419.
115. 115. Sanders DS, Evans AT, Allen CA et al. Classification of CEA-related positivity in primary and metastatic malignant melanoma. J. Pathol. 1994; 172; 343-348.
116. 116. Truong LD, Rangdaeng S, Cagle P, Ro JY, Hawkins H, Font RL. The diagnostic utility of desmin: a study of 584 cases and review of the literature. Am. J. Clin. Pathol. 1990; 93; 305-314.
117. 117. Facchetti F, Bertalot G, Grigolato PG. KP1 (CD68) staining of malignant melanomas. Histopathology 1991; 19; 141-145.
118. 118. Gloghini A, Rizzo A, Zanette I et al. KP1/CD68 expression in malignant neoplasms including lymphomas, sarcomas and carcinomas. Am. J. Clin. Pathol. 1995; 103; 425-431.